Target Name: NAAA
NCBI ID: G27163
Review Report on NAAA Target / Biomarker Content of Review Report on NAAA Target / Biomarker
NAAA
Other Name(s): ASAH-like protein | NAAA variant 1 | Acylsphingosine deacylase NAAA | ASAHL | PLT | N-acylethanolamine-hydrolyzing acid amidase subunit alpha | N-acylsphingosine amidohydrolase-like | acid ceramidase-like protein | acylsphingosine deacylase NAAA | N-acylethanolamine acid amidase, transcript variant 2 | N-acylethanolamine-hydrolyzing acid amidase subunit beta | NAAA_HUMAN | Acid ceramidase-like protein | N-acylethanolamine acid amidase | N-acylethanolamine acid amidase, transcript variant 1 | NAAA variant 2 | N-acylethanolamine-hydrolyzing acid amidase | N-acylsphingosine amidohydrolase (acid ceramidase)-like | N-acylethanolamine-hydrolyzing acid amidase (isoform 1) | N-acylethanolamine-hydrolyzing acid amidase (isoform 2)

Understanding The Unlikely: The Unveiled Structure of NAAA

NAAA, or N-acetylated alpha-helix protein, is a protein that is expressed in a wide range of tissues throughout the body. It is a member of the alpha-helix family of proteins, which are known for their unique structure and stability. NAAA is characterized by its N-acetylated alpha-helical residues, which give it its unique acetylated status.

The protein NAAA is involved in many different cellular processes, including cell signaling, DNA replication, and protein synthesis. It is a key player in the regulation of cell growth and differentiation, and is thought to play a role in the development and progression of many diseases.

Despite its importance, the protein NAAA has not yet been fully understood. There is limited research on its structure and function, and it is not clear what the best way to study it is. However, its potential as a drug target or biomarker makes it an important area of 鈥嬧?媠tudy.

One way to study NAAA is through its function as a drug target. NAAA has been shown to interact with a variety of small molecules, including pharmaceuticals. This suggests that NAAA may be a useful target for the development of new drugs for a variety of diseases . For example, NAAA has been shown to interact with the drug inhibitor PD-1, leading to the potential for a drug that blocks the interaction between NAAA and PD-1 to be a treatment for cancer.

Another way to study NAAA is through its function as a biomarker. NAAA has been shown to be expressed in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that NAAA may be a useful biomarker for the diagnosis and prognosis of these diseases. For example, NAAA has been shown to be expressed in the brains of people with Alzheimer's disease, leading to the potential for NAAA to be used as a diagnostic marker for this disease.

In addition to its potential as a drug target and biomarker, NAAA is also of interest to researchers because of its unique structure. The N-acetylated alpha-helical residues give NAAA its unique acetylated status, and the structure of these residues is thought to be involved in its function. Researchers are interested in understanding how these residues interact with other parts of the protein to give NAAA its unique structure and stability.

Overall, the protein NAAA is an important area of 鈥嬧?媠tudy because of its potential as a drug target and biomarker. While more research is needed to fully understand its structure and function, its unique properties make it an intriguing target for researchers to study.

Protein Name: N-acylethanolamine Acid Amidase

Functions: Degrades bioactive fatty acid amides to their corresponding acids, with the following preference: N-palmitoylethanolamine > N-myristoylethanolamine > N-lauroylethanolamine = N-stearoylethanolamine > N-arachidonoylethanolamine > N-oleoylethanolamine (PubMed:15655246, PubMed:17980170, PubMed:18793752, PubMed:30301806, PubMed:22825852). Also exhibits weak hydrolytic activity against the ceramides N-lauroylsphingosine and N-palmitoylsphingosine (PubMed:15655246)

The "NAAA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NAAA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NAALAD2 | NAALADL1 | NAALADL2 | NAALADL2-AS3 | NAB1 | NAB2 | NABP1 | NABP2 | NACA | NACA2 | NACA3P | NACA4P | NACAD | NACC1 | NACC2 | NAD(P)H dehydrogenase, quinone | NAD-Dependent Protein Deacetylase | NADH dehydrogenase (Complex I) | NADK | NADK2 | NADPH Oxidase | NADPH Oxidase Complex | NADSYN1 | NAE1 | NAF1 | NAG18 | NAGA | NAGK | NAGLU | NAGPA | NAGPA-AS1 | NAGS | NAIF1 | NAIP | NAIPP2 | NALCN | NALCN sodium channel complex | NALCN-AS1 | NALF1 | NALF2 | NALT1 | NAMA | NAMPT | NAMPTP1 | NANOG | NANOGNB | NANOGP1 | NANOGP8 | NANOS1 | NANOS2 | NANOS3 | NANP | NANS | NAP1L1 | NAP1L1P1 | NAP1L2 | NAP1L3 | NAP1L4 | NAP1L4P1 | NAP1L5 | NAP1L6P | NAPA | NAPA-AS1 | NAPB | NAPEPLD | NAPG | NAPRT | NAPSA | NAPSB | NARF | NARS1 | NARS2 | Nascent polypeptide-associated complex | NASP | NAT1 | NAT10 | NAT14 | NAT16 | NAT2 | NAT8 | NAT8B | NAT8L | NAT9 | NATD1 | Natural cytotoxicity triggering Receptor | NAV1 | NAV2 | NAV2-AS5 | NAV2-AS6 | NAV3 | NAXD | NAXE | nBAF complex | NBAS | NBAT1 | NBDY | NBEA | NBEAL1 | NBEAL2 | NBEAP1